Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04157153 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

First in Men Study: BIOMAG-I

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 22, 2022 (before its estimated August 2022 completion). Its status may not reflect the trial's current state.

Record History

  1. Minor Completion date: Dec 2024 to Feb 2027 Study description revisedv7 Show 1 more changeShow less
  2. Minor Trial status: Recruiting to Active, Not Recruiting Enrollment target: estimated 115 to confirmed 116 · Site details revised at 14 of 14 sitesv6 Show 2 more changesShow less
    • Enrollment target: estimated 115 to confirmed 116
    • Site details revised at 14 of 14 sites
  3. Notable Primary completion date: Feb 2021 to Aug 2022 Completion date: Aug 2023 to Dec 2024 · Site details revised at 11 of 14 sitesv5 Show 2 more changesShow less
    • Completion date: Aug 2023 to Dec 2024
    • Site details revised at 11 of 14 sites
  4. Minor Site details revised at 1 of 14 sitesv4
  5. Minor Site details revised at 1 of 14 sitesv3
  6. Notable Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Mar 2020 to Apr 27, 2020 · Site details revised at 14 of 14 sitesv2 Show 2 more changesShow less
    • Start date changed from estimate of Mar 2020 to Apr 27, 2020
    • Site details revised at 14 of 14 sites
  7. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A prospective, multi-center, first-in-man trial. Up to 115 subjects will be enrolled.
Trial Details
NCT Number NCT04157153
Lead Sponsor Biotronik AG
Conditions Coronary Artery Disease
Enrollment 116 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov